1108
For the first time in 25 years opened a new antibiotic
Experimental antibiotic "teyksobaktin" can be a remedy against infections annually kill hundreds of thousands of people, he will help fight antibiotic-resistant Staphylococcus aureus and tuberculosis.
Staphylococcus aureus thrives in the nasal passages and axillary regions of healthy people. Its carriers are between 30% and 50% of children aged 4-6 years and 15-20% of adults. Methicillin-resistant Staphylococcus aureus species in the US alone kills more than 20,000 people a year, about 30% of all cases.
TB - common in the world of infectious disease that affects the lungs and other organs. This disease is transmitted from person to person via droplets from the throat and lungs. One of the most difficult to treat species - multidrug resistant : he does not respond to isoniazid and rifampicin , the two most powerful anti-TB drugs. In 2012, this species was diagnosed in 450,000 people. On данным World Health Organization, in 2013, died of tuberculosis 1, 5 million people.
The problem of treating complicated by the fact that bacteria are becoming resistant to antibiotics. I>
A new antibiotic that can change the pattern of mortality from these diseases, ученые almost got out of the mud : in the study of bacteria on the grass fields of New England, Maine. He was received as a result of a collaborative effort of scientists from Germany, the UK and the US. "Teyksobaktin" was isolated from bacteria Eleftheria terrae.
Eleftheria terrae i>
Testing "teyksobaktina" on laboratory mice showed that he is able to heal the animal from multidrug-resistant strains of Staphylococcus aureus, while there was no evidence of any side effects. Testing «in vitro», that is, "in glass", showed the ability to destroy antibiotic resistant strains of a number of infections such as anthrax, the causative agent of diarrhea - Clostridium, tubercle bacilli and staphylococci.
With luck, antibiotic capsules will appear in 2019.
Source: geektimes.ru/post/243983/
Staphylococcus aureus thrives in the nasal passages and axillary regions of healthy people. Its carriers are between 30% and 50% of children aged 4-6 years and 15-20% of adults. Methicillin-resistant Staphylococcus aureus species in the US alone kills more than 20,000 people a year, about 30% of all cases.
TB - common in the world of infectious disease that affects the lungs and other organs. This disease is transmitted from person to person via droplets from the throat and lungs. One of the most difficult to treat species - multidrug resistant : he does not respond to isoniazid and rifampicin , the two most powerful anti-TB drugs. In 2012, this species was diagnosed in 450,000 people. On данным World Health Organization, in 2013, died of tuberculosis 1, 5 million people.
The problem of treating complicated by the fact that bacteria are becoming resistant to antibiotics. I>
A new antibiotic that can change the pattern of mortality from these diseases, ученые almost got out of the mud : in the study of bacteria on the grass fields of New England, Maine. He was received as a result of a collaborative effort of scientists from Germany, the UK and the US. "Teyksobaktin" was isolated from bacteria Eleftheria terrae.
Eleftheria terrae i>
Testing "teyksobaktina" on laboratory mice showed that he is able to heal the animal from multidrug-resistant strains of Staphylococcus aureus, while there was no evidence of any side effects. Testing «in vitro», that is, "in glass", showed the ability to destroy antibiotic resistant strains of a number of infections such as anthrax, the causative agent of diarrhea - Clostridium, tubercle bacilli and staphylococci.
With luck, antibiotic capsules will appear in 2019.
Source: geektimes.ru/post/243983/
CES 2015: What's New intelligent electronics for January 7,
Travel posters by NASA for travelers on exoplanets